Bernd Winterhalter
Corporate Officer/Principal chez CureVac SE
Postes actifs de Bernd Winterhalter
Sociétés | Poste | Début | Fin |
---|---|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | 01/12/2019 | - |
Historique de carrière de Bernd Winterhalter
Anciens postes connus de Bernd Winterhalter
Sociétés | Poste | Début | Fin |
---|---|---|---|
CUREVAC N.V. | Corporate Officer/Principal | 01/12/2019 | 01/02/2021 |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Directeur Technique/Scientifique/R&D | 01/01/2004 | 01/01/2018 |
Pharmacia GmbH | Directeur Technique/Scientifique/R&D | 01/01/1997 | 01/01/2003 |
Formation de Bernd Winterhalter
University of Freiburg | Doctorate Degree |
Statistiques
Internationale
Allemagne | 6 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Entreprise privées | 3 |
---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Pharmacia GmbH | |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |
- Bourse
- Insiders
- Bernd Winterhalter
- Expérience